Cleared Traditional

K140575 - ENGSTROM CARESTATION, ENGSTROM PRO

K140575 is an FDA 510(k) clearance for ENGSTROM CARESTATION, manufactured by Datex-Ohmeda, Inc.. The device is a Class 2 Anesthesiology device with product code CBK cleared through the Traditional 510(k) pathway after a 334-day FDA review.

K140575 · Datex-Ohmeda, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2015
Decision
334d
Days
Class 2
Risk

K140575 is an FDA 510(k) clearance for the ENGSTROM CARESTATION, ENGSTROM PRO. Classified as Ventilator, Continuous, Facility Use (product code CBK), Class II - Special Controls.

Submitted by Datex-Ohmeda, Inc. (Madison, US). The FDA issued a Cleared decision on February 3, 2015 after a review of 334 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5895 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Datex-Ohmeda, Inc. devices

FDA 510(k) Submission Details - K140575

510(k) Number K140575 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2014
Decision Date February 03, 2015
Days to Decision 334 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
194d slower than avg
Panel avg: 140d · This submission: 334d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CBK Device Classification - Class 2, Special Controls

Product Code CBK Ventilator, Continuous, Facility Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5895
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBK Ventilator, Continuous, Facility Use

All 367
Devices cleared under the same product code (CBK) and FDA review panel - the closest regulatory comparables to K140575.
HAMILTON-T1,HAMILTON-C1
K140939 · Hamilton Medical AG · Sep 2015
BREATHE TECHNOLOGIES LIFE2000 VENTILATION SYSTEM
K141943 · Breathe Technologies · Jun 2015
CARESCAPE R860
K142679 · Datex-Ohmeda, Inc. · Jun 2015
SAVINA 300 SAVINA 300, COUNTRY VARIANTS
K121886 · Draeger Medical GmbH · Aug 2014
SERVO-I VENTILATOR SYSTEM
K123149 · Maquet Critical Care AB · Jun 2014
ASTRAL VENTILATOR
K133868 · Resmed, Ltd. · Jun 2014